Dapagliflozin is a drug used to treat endocrine and metabolic disorders. It belongs to a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which work by blocking the reabsorption of glucose in the kidneys, leading to increased excretion of glucose in the urine. This helps to reduce blood sugar levels in people with type 2 diabetes. Dapagliflozin is also used to reduce the risk of cardiovascular events in adults with type 2 diabetes. Dapagliflozin is available in both tablet and oral solution form and is typically taken once daily. Common side effects include urinary tract infections, increased urination, and genital yeast infections. The Dapagliflozin market is highly competitive, with several major pharmaceutical companies offering the drug. These include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, and Novo Nordisk. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
